A Case of Shield Ulcer Due to Vernal Keratoconjunctivitis
IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, cilt.20, sa.4, ss.505-508, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 20 Sayı: 4
- Basım Tarihi: 2021
- Doi Numarası: 10.18502/ijaai.v20i4.6961
- Dergi Adı: IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
- Sayfa Sayıları: ss.505-508
- Anahtar Kelimeler: Cyclosporine, Vernal keratoconjunctivitis, TOPICAL CYCLOSPORINE, 0.05-PERCENT, MANAGEMENT, PLAQUES
- Süleyman Demirel Üniversitesi Adresli: Evet
Özet
Corneal shield ulcer is an uncommon but serious complication of vernal keratoconjunctivitis (VKC) that can threaten visual acuity. We present a 12-year-old case with a corneal shield ulcer on the superior part of the cornea in the right eye. We learned from his history that he was treated with topical cyclosporine A (CsA) and corneal debridement was performed for the same complaints six months ago. His complaints recurred six months after ceasing topical CsA voluntarily. Topical anti-allergic and CsA treatments were commenced, we also performed corneal debridement. During his followups, the corneal ulcer healed leaving a scar as opacity and neovascularization. This case highlights the role of the anti-inflammatory effect of CsA in preventing the recurrence of shield ulcers.